STOCK TITAN
  1. Home
  2. Sec-filings
  3. NVVE
  4. [Form 4] Nuvve Holding Corp. Insider Trading Activity

Nuvve CEO & director report major RSU and option grants

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Nuvve Holding Corp. (NVVE) reported an insider equity award to its Chief Executive Officer and director. On 11/19/2025, the CEO received 1,323,000 restricted stock units (RSUs) that vested immediately, with each RSU delivering one share of Nuvve common stock at a price of $0 per share. Following this grant, he held 1,656,474.78 shares of common stock directly.

On the same date, he was also granted 2,000,000 employee stock options with an exercise price of $0.195 per share, exercisable into Nuvve common stock. These options vest on December 31, 2025 and expire on November 19, 2035. After this transaction, he beneficially owned 2,002,312 derivative securities, all held directly.

Positive

  • None.

Negative

  • None.
Insider Poilasne Gregory
Role Chief Executive Officer
Type Security Shares Price Value
Grant/Award Employee Stock Option (Right to Buy) 2,000,000 $0.00 --
Grant/Award Common Stock 1,323,000 $0.00 --
Holdings After Transaction: Employee Stock Option (Right to Buy) — 2,002,312 shares (Direct); Common Stock — 1,656,474.78 shares (Direct)
Footnotes (1)
  1. The securities awarded are in the form of restricted stock units (RSUs) issued pursuant to the Issuer's Amended and Restated 2020 Long-Term Incentive Plan. Each RSU, which vested immediately, represents the right to receive one share of the Issuer's common stock. The securities awarded are in the form of Employee Stock Options (Right to Buy) issued pursuant to the Issuer's Amended and Restated 2020 Long-Term Incentive Plan and vest on December 31, 2025.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Poilasne Gregory
(Last) (First) (Middle)
C/O NUVVE HOLDING CORP.
2488 HISTORIC DECATUR ROAD, SUITE 230
(Street)
SAN DIEGO CA 92106
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Nuvve Holding Corp. [ NVVE ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
11/19/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock(1) 11/19/2025 A 1,323,000 A $0 1,656,474.78 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy) $0.195 11/19/2025 A 2,000,000 12/31/2025 11/19/2035 Common Stock 2,000,000(2) $0 2,002,312 D
Explanation of Responses:
1. The securities awarded are in the form of restricted stock units (RSUs) issued pursuant to the Issuer's Amended and Restated 2020 Long-Term Incentive Plan. Each RSU, which vested immediately, represents the right to receive one share of the Issuer's common stock.
2. The securities awarded are in the form of Employee Stock Options (Right to Buy) issued pursuant to the Issuer's Amended and Restated 2020 Long-Term Incentive Plan and vest on December 31, 2025.
Remarks:
/s/ Gregory Poilasne 11/21/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Nuvve Holding Corp. (NVVE) report?

Nuvve reported an equity award to its Chief Executive Officer and director, consisting of restricted stock units and employee stock options in Nuvve common stock.

How many RSUs did the Nuvve (NVVE) CEO receive in this Form 4?

The CEO received 1,323,000 restricted stock units (RSUs), each representing one share of Nuvve common stock, and these RSUs vested immediately at a price of $0 per share.

What stock options were granted to the Nuvve (NVVE) CEO?

He was granted 2,000,000 employee stock options with an exercise price of $0.195 per share, exercisable for Nuvve common stock.

When do the new Nuvve (NVVE) stock options vest and expire?

The options vest on December 31, 2025 and have an expiration date of November 19, 2035.

How many Nuvve (NVVE) common shares does the CEO own after this transaction?

After the reported RSU grant, the CEO directly owned 1,656,474.78 shares of Nuvve common stock.

How many derivative securities does the Nuvve (NVVE) CEO own after this transaction?

Following the option grant, the CEO beneficially owned 2,002,312 derivative securities, held directly.

Under what plan were the Nuvve (NVVE) RSUs and options granted?

Both the RSUs and the employee stock options were granted under Nuvve’s Amended and Restated 2020 Long-Term Incentive Plan.